temoloz TEMOZOLOMIDE

Introduction to temoloz

Temoloz is a medication primarily used to treat certain aggressive brain tumors, such as glioblastoma multiforme and anaplastic astrocytoma. Temoloz is available in tablet form and is a crucial part of cancer treatment regimens.

Composition of temoloz

Temoloz contains the active ingredient Temozolomide, which belongs to a class of drugs known as alkylating agents. These agents work by adding an alkyl group to the DNA of cancer cells, causing damage that prevents the cells from growing and dividing.

Uses of temoloz

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of temoloz

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: severe bone marrow suppression, increased risk of infection

Precautions of temoloz

Patients taking temoloz should be aware that it can lower blood cell counts, increasing the risk of infections. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Patients with severe bone marrow suppression should avoid using this medication.

How to Take temoloz

Temoloz is typically taken orally on an empty stomach, either one hour before or two hours after a meal. The usual starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. Always follow your doctor's advice for the correct dosage and administration method.

Conclusion of temoloz

In conclusion, temoloz, containing the active ingredient Temozolomide, is an important medication in the therapeutic class of alkylating agents. It is primarily used to treat aggressive brain tumors like glioblastoma multiforme and anaplastic astrocytoma. Patients should be aware of its side effects and precautions, especially regarding blood cell counts and pregnancy. Temoloz is manufactured by various pharmaceutical companies and plays a vital role in cancer treatment protocols.